Pubblicazioni

Autori:

Bassetti, M.; Peghin, M.; Carnelutti, A.; Righi, E.

Titolo:

How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae?

Anno:

2017

Tipologia prodotto:

Articolo in Rivista

Tipologia ANVUR:

Articolo su rivista

Lingua:

Inglese

Referee:

No

Nome rivista:

SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

ISSN Rivista:

1069-3424

N° Volume:

38

Numero o Fascicolo:

3

Editore:

Thieme Medical Publishers Incorporated:333 Seventh Avenue:New York, NY 10001:(800)782-3488, (212)760-0888, EMAIL: custserv@thieme.com, INTERNET: http://www.thieme.com, Fax: (212)947-0108

Intervallo pagine:

301-310

Parole chiave:

hospital-acquired pneumonia; ventilator-acquired pneumonia; carbapenemase-producing Enterobacteriaceae; antibiotic therapy; multidrug-resistant gram negative

Breve descrizione dei contenuti:

Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) represent a common problem in hospital setting worldwide. Infections caused by carbapenem-resistant Enterobacteriaceae (CRE) are an emergent problem due to the lack of therapeutic options available, leading to significant increases in morbidity and mortality. CRE have frequently been reported both in HAP/VAP, but limited data regarding the optimal treatment strategy in this setting are available. This review focuses on the current epidemiology of CRE, with a specific focus on HAP/VAP. Moreover, we will suggest a possible strategy for the empiric and targeted treatment of HAP and VAP in which the involvement of CRE is suspected or is confirmed.

Id prodotto:

126955

Handle IRIS:

11562/1065336

ultima modifica:

28 marzo 2023

Citazione bibliografica:

Bassetti, M.; Peghin, M.; Carnelutti, A.; Righi, E., How Should We Treat HAP/VAP Caused by Carbapenemase-Producing Enterobacteriaceae? «SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE» , vol. 38 , n. 3 , 2017 , pp. 301-310

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo